Figure 1. 2nd MSA patient on nasal foralumab

Figure 1. 2nd MSA patient on nasal foralumab

Significant reduction in basal ganglia and thalamic uptake following nasal foralumab

Format

PNG

Source

Tiziana Life Sciences Ltd.

Téléchargements